Clinicopathological significance of claudin-4 in gastric carcinoma
Open Access
- 4 July 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in World Journal of Surgical Oncology
- Vol. 11 (1), 150-9
- https://doi.org/10.1186/1477-7819-11-150
Abstract
Background Aberrant expression of claudin proteins has been reported in a variety of cancers. Previous studies have demonstrated that overexpression of claudin may promote tumorigenesis and metastasis through increased invasion and survival of tumor cells. However, the prognostic significance of claudin-4 in gastric cancer remains unclear. Methods Immunohistochemistry was used to analyze the expression of claudin-4 in 329 clinical gastric cancer specimens and 44 normal stomach samples, 21 intestinal metaplasia samples, and 21 adjacent precursor lesions dysplasia samples. Statistical analysis methods were used to evaluate the relationship between claudin-4 expression and various clinicopathological parameters. Univariate and multivariate analyses were performed, respectively, to detect the independent predictors of survival. Results Claudin-4 expression was present in only 7(15.9%) normal gastric samples, but expression of claudin-4 in the intestinal metaplasia lesions and dysplasia lesions was 90.5% and 95.2%, respectively. The expression of claudin-4 was significantly associated with histological differentiation (P < 0.001) and tumor growth patterns (P < 0.001) but not associated with patient survival. However, intermediate type staining of claudin-4 exhibited a trend of correlation with patients’ survival (P = 0.023). The five-year survival rate with low expression of claudin-4 in intermediate type (76.4%) was similar to expanding type (64.5%), while the high expression group (46.6%) was closer to infiltrative type (50.7%). Conclusions The findings in this study demonstrate claudin-4 aberrant expression in gastric cancer and precursor lesions. The expression of claudin-4 could serve as a basis for identifying gastric cancer of the intermediate type.Keywords
This publication has 39 references indexed in Scilit:
- Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinomaLaboratory Investigation, 2011
- Turn a diarrhoea toxin into a receptor-mediated therapy for a plethora of CLDN-4-overexpressing cancersBiochemical and Biophysical Research Communications, 2010
- Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer.2009
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Gastric and intestinal claudin expression at the invasive front of gastric carcinomaCancer Science, 2007
- Claudin-4, Mitogen-Activated Protein Kinase Kinase 4, and Stratifin Are Markers of Gastric Adenocarcinoma Precursor LesionsCancer Epidemiology, Biomarkers & Prevention, 2006
- Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtypeVirchows Archiv, 2005
- Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research studyBreast Cancer Research, 2005
- Tight junction proteinsProgress in Biophysics and Molecular Biology, 2003
- Conversion of Zonulae Occludentes from Tight to Leaky Strand Type by Introducing Claudin-2 into Madin-Darby Canine Kidney I CellsThe Journal of cell biology, 2001